05/21/2024 4:27 PM | Neurocrine Biosciences (Issuer) POPS RICHARD F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:35 PM | Neurocrine Biosciences (Issuer) Sharp Shalini (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:15 PM | MORROW GEORGE J (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 3:57 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:06 PM | Neurocrine Biosciences (Issuer) Norwalk Leslie V (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 3:51 PM | Neurocrine Biosciences (Issuer) SHERWIN STEPHEN A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 3:46 PM | Mercier Johanna (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
05/17/2024 3:31 PM | Neurocrine Biosciences (Subject) Norwalk Leslie V (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024 3:31 PM | Neurocrine Biosciences (Subject) Sharp Shalini (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024 3:32 PM | Neurocrine Biosciences (Subject) POPS RICHARD F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 3:40 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2024 3:23 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024 3:26 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/01/2024 6:01 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/01/2024 6:03 AM | Neurocrine Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/17/2024 4:19 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2024 3:29 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024 3:40 PM | Neurocrine Biosciences (Filer)
| Form ARS | |
04/10/2024 3:31 PM | Neurocrine Biosciences (Filer)
| Form DEFA14A | |
04/10/2024 3:07 PM | Neurocrine Biosciences (Filer)
| Form DEF 14A | |
04/03/2024 3:44 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/25/2024 5:02 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2024 3:20 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 4:25 PM | MORROW GEORGE J (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 4:33 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 4:15 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 4:19 PM | Neurocrine Biosciences (Issuer) POPS RICHARD F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 3:32 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024 3:33 PM | MORROW GEORGE J (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024 5:47 PM | Neurocrine Biosciences (Issuer) Neurocrine Biosciences (Issuer) POPS RICHARD F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:38 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 3:22 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024 3:22 PM | Neurocrine Biosciences (Subject) POPS RICHARD F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 5:55 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 6:02 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 5:50 PM | Neurocrine Biosciences (Issuer) Norwalk Leslie V (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 4:11 PM | Neurocrine Biosciences (Issuer) POPS RICHARD F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:51 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:40 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:43 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:45 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
What is Nvidia’s New $1 Trillion Superproject? (Ad) Nvidia recently added $277 billion in market cap …
IN ONE DAY. Find out details on these three critical Nvidia partners immediately. |
02/15/2024 4:48 PM | Neurocrine Biosciences (Issuer) Onyia Jude (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:27 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:29 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:33 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:35 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:38 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 4:17 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 3:18 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 3:19 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 3:19 PM | Neurocrine Biosciences (Subject) ROBERTS EIRY (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 3:20 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 3:20 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024 4:29 PM | Neurocrine Biosciences (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/08/2024 6:46 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:35 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:21 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:25 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:28 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:12 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:15 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:17 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 3:21 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/08/2024 3:21 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024 6:00 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 6:21 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:24 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:26 PM | Neurocrine Biosciences (Issuer) Onyia Jude (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:29 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:00 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:05 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:07 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:11 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:14 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:17 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 3:43 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024 4:04 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024 4:47 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 10:52 AM | BlackRock Inc. (Filed by) Neurocrine Biosciences (Subject)
| Form SC 13G/A | |
01/22/2024 3:17 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024 3:31 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:15 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 5:26 PM | Neurocrine Biosciences (Issuer) RASTETTER WILLIAM H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 5:32 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:31 PM | Neurocrine Biosciences (Subject) RASTETTER WILLIAM H (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024 3:31 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023 3:08 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2023 3:10 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2023 3:15 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 3:21 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 3:22 PM | Neurocrine Biosciences (Subject) ROBERTS EIRY (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Write this ticker symbol down… (Ad) A megatrend now poised to mint a brand-new wave of millionaires right here in America.
And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything. Discover the #1 company leading this revolution |
12/22/2023 3:22 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 4:22 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 5:18 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/08/2023 6:09 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/08/2023 5:23 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 3:32 PM | Neurocrine Biosciences (Subject) ROBERTS EIRY (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023 3:33 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/05/2023 3:54 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Issuer) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 7:01 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |